Back to top

Image: Bigstock

Why Sanofi (SNY) is a Great Dividend Stock Right Now

Read MoreHide Full Article

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.

Sanofi in Focus

Headquartered in Paris, Sanofi (SNY - Free Report) is a Medical stock that has seen a price change of -3.65% so far this year. Currently paying a dividend of $1.21 per share, the company has a dividend yield of 2.51%. In comparison, the Large Cap Pharmaceuticals industry's yield is 2.59%, while the S&P 500's yield is 2.19%.

Looking at dividend growth, the company's current annualized dividend of $1.21 is up 4.7% from last year. In the past five-year period, Sanofi has increased its dividend 2 times on a year-over-year basis for an average annual increase of 1.86%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Right now, Sanofi's payout ratio is 33%, which means it paid out 33% of its trailing 12-month EPS as dividend.

Looking at this fiscal year, SNY expects solid earnings growth. The Zacks Consensus Estimate for 2020 is $3.42 per share, representing a year-over-year earnings growth rate of 3.01%.

Bottom Line

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. But, not every company offers a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. That said, they can take comfort from the fact that SNY is not only an attractive dividend play, but also represents a compelling investment opportunity with a Zacks Rank of #2 (Buy).

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sanofi (SNY) - free report >>

Published in